Article
Upregulation of Soluble HLA-G in Chronic Left Ventricular Systolic Dysfunction.
Journal of immunology research - 1 Jan 2016
Olesen Line Lisbeth, Hviid Thomas Vauvert F
Abstract excerpt
Left ventricular systolic dysfunction (LVSD) defined by ejection fraction (EF) <40% is common, serious but treatable, and correct diagnosis is the cornerstone of effective treatment. Biomarkers may help to diagnose LVSD and give insight into the pathophysiology. The immune system is activated in LVSD, and the immunomodulatory molecule human leukocyte antigen-G (HLA-G) may be involved. The primary aim was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
